Goldman Sachs Group Inc Ptc Therapeutics, Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
308Shares Held
80.1MCall Options Held
255KPut Options Held
151K-
Vanguard Group Inc Valley Forge, PA8.85MShares$578 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$508 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$506 Million5.81% of portfolio
-
Armistice Capital, LLC New York, NY4.74MShares$310 Million4.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.69MShares$307 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $4.68B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...